This inventor holds 1 USPTO granted patent. Top assignee: Amgen Inc.. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: Simon Van Der Plas: Innovator in Heterocyclic Compounds
Introduction
Simon Van Der Plas is a notable inventor based in Medford, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of heterocyclic compounds. His work focuses on compounds that are effective for the prophylaxis and treatment of diseases, including those mediated by angiogenesis.
Latest Patents
Simon holds 1 patent for his invention titled "Heterocyclic compounds and methods of use." This patent encompasses novel compounds, analogs, prodrugs, and pharmaceutically acceptable salts. The compounds are designed for the prophylaxis and treatment of various diseases, including cancer and related conditions. The invention also details processes for making these compounds and intermediates useful in such processes.
Career Highlights
Simon is currently employed at Amgen Inc., a leading biotechnology company. His work at Amgen has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry. His expertise in heterocyclic compounds has positioned him as a valuable asset in the fight against serious diseases.
Collaborations
Some of Simon's notable coworkers include Lucian V Di Pietro and Daniel Elbaum. Their collaborative efforts contribute to the innovative environment at Amgen, fostering advancements in medical research and drug development.
Conclusion
Simon Van Der Plas is a distinguished inventor whose work in heterocyclic compounds has the potential to impact the treatment of serious diseases. His contributions to Amgen Inc. and the pharmaceutical field highlight the importance of innovation in healthcare.